Cours Summit Therapeutics plc London S.E.
Actions
GB00BN40HZ01
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 2,46 Md 3,08 Md 2,79 Md |
---|---|---|---|---|---|
Résultat net 2024 * | - | Résultat net 2025 * | - | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 11,88% |
Dernier transcript sur Summit Therapeutics plc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Director of Finance/CFO | 46 | 01/12/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Robert Booth
BRD | Director/Board Member | 70 | 28/09/22 |
Director of Finance/CFO | 46 | 01/12/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+6,79% | 14,16 Md | |
+38,61% | 12,63 Md |